Varus Medical, UAB - financials and debts

Company age: 19 y. 0 mo.

Update

Varus Medical - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 125,810 568,791 176,002 137,124 214,012 896,031
Profit before tax - 7,837 56,418 94,359 -2,061 -42,308 10,201
Net profit -6,073 7,410 56,418 80,205 -2,061 -42,308 8,443
Equity 13 11,524 149,820 230,025 227,964 185,657 194,100
Liabilities 0 121,663 522,513 634,088 662,219 642,946 811,992
Non-current assets 0 0 0 0 34,764 34,749 18,555
Current assets 13 133,143 672,118 864,113 855,419 793,854 987,537
Total assets 13 133,143 672,118 864,113 890,183 828,603 1,006,092
Taxes paid
STI taxes - - - - 11,768 3,285 416
Social insurance contributions - - - - 8,105 - 4,741
Financial indicators
Revenue change y/y - - +352.1% -69.1% -22.1% +56.1% +318.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -46715.4% 5.6% 8.4% 9.3% -0.2% -5.1% 0.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -46715.4% 64.3% 37.7% 34.9% -0.9% -22.8% 4.3%
Profit margin Net profit margin. Shows the overall profitability of the company. - 5.9% 9.9% 45.6% -1.5% -19.8% 0.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - 6.2% 9.9% 53.6% -1.5% -19.8% 1.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 10.6 3.5 2.8 2.9 3.5 4.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 125,810 401,490 58,667 30,472 71,337 244,370

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Varus Medical - Social security debts

From To Debt, €
2026-07-23 2026-08-04 0.49
2026-06-16 2026-06-22 453.62
2025-10-16 2025-10-19 602.75
2025-07-26 2025-07-31 0.26
2025-06-17 2025-06-24 0.83
2025-05-04 2025-05-08 1.53
2025-04-17 2025-04-30 1.53
2025-04-16 2025-04-16 479.70
2025-01-22 2025-02-12 0.83
2024-10-24 2024-11-05 4.38
2024-10-16 2024-10-21 407.94
2024-09-17 2024-09-18 819.35
2024-08-19 2024-09-16 411.41
2024-07-24 2024-08-18 1.66
2024-05-30 2024-06-10 0.77
2024-05-16 2024-05-29 408.71
2024-04-23 2024-05-15 0.77
2024-02-19 2024-02-25 0.89
2024-01-23 2024-02-12 0.79
2024-01-16 2024-01-17 851.05
2023-11-16 2023-12-20 0.10
2023-10-25 2023-11-14 0.10
2023-08-17 2023-08-21 1.39
2023-07-28 2023-08-07 1.39
2023-07-24 2023-07-25 1.43
2023-07-19 2023-07-23 84.41
2023-06-16 2023-06-20 695.97
2023-05-16 2023-06-15 2.78
2023-03-16 2023-03-19 856.31
2023-02-28 2023-03-15 213.46
2023-02-17 2023-02-27 643.36
2023-02-06 2023-02-16 0.51
2023-01-24 2023-02-03 0.51
2023-01-20 2023-01-22 0.51
2022-11-21 2022-12-05 13.97
2022-11-17 2022-11-18 503.98
2022-10-28 2022-11-16 1.76
2022-08-23 2022-08-24 502.04
2022-05-17 2022-05-19 490.50
2022-04-19 2022-04-21 490.50
2021-11-16 2021-11-16 298.44

Varus Medical - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Varus Medical, UAB (code 301128760) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €896.0K, up from €214.0K in 2024 and €137.1K in 2023, showing a strong expansion in turnover over the latest two-year period. The latest year ended with net profit of €8.4K, compared with a loss of €42.3K in 2024 and a loss of €2.1K in 2023, indicating a return to profitability after a weaker prior year. The 2025 profit margin was 0.9%, reflecting modest profitability on the higher revenue base. At the end of 2025, total assets stood at €1.01M, with equity of €194.1K and liabilities of €812.0K. The equity ratio was 19.3% and debt-to-equity stood at 4.18, showing a leveraged balance sheet. Asset turnover was 0.89x, ROE was 4.3% and ROA was 0.8%. Revenue per employee reached €298.7K, while profit per employee was €2.8K.